| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |